Diligence memo · auto-generated · as of July 2, 2026
Insono Therapeutics, Inc.
Insono Therapeutics, Inc. looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Insono Therapeutics, Inc. operates in Other Health Care, based in PALO ALTO.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Insono Therapeutics, Inc. has raised $210K in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $210K on 2012-07-25.
Most recent recorded round closed around 2012-07-25.
Valuation (modeled)modeled
Provath models Insono Therapeutics, Inc. at approximately $6.5M (range $132K–$73M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.70× the median modeled value of Pre-Seed Other Health Care companies in 2010–2012 (351 peers) — value vs value, same stage and era. Within the normal band (70% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 13.9 yr ago; this sector typically re-raises about every 14 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 10% of Other Health Care peers (5377 compared).
Modeled value ranks above 26% of those peers.
Closest niche peers: Chrysallis, Inc., RefillDRS, LLC, Ageology LLC, Great Lakes Healthcare Fund I, LLC, CreateHealth, Inc..
Peoplefiled
2 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.